Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve please refer attachement
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emmessar Biotech & Nutrition Ltd has informed BSE that its Board of Directors meeting is scheduled for May 12, 2026. The meeting will consider and approve the Audited Financial Results for the year ended March 31, 2026. The company has also confirmed that the trading window will remain closed until May 14, 2026, in compliance with SEBI Insider Trading Regulations. This is a standard regulatory intimation filed pursuant to Regulation 29(1)(a) of the SEBI LODR Regulations. No financial details or preliminary numbers are disclosed in this notice.
This is a routine pre-result announcement with no immediate impact on shareholders. The actual financial results and their implications for the stock will only be known after the board meeting on May 12, 2026.